Prescription Drug Affordability Advisory Council elimination

This bill eliminates the Prescription Drug Affordability Advisory Council in Minnesota and transfers its regulatory duties to the Department of Commerce. The legislation redefines how conflicts of interest are handled for officials reviewing drug prices and mandates that the Commerce Commissioner identify specific high-cost prescription drugs based on set criteria like price increases and total cost. Additionally, the bill appropriates $1.75 million to the Department of Commerce for these new responsibilities while reducing funding for the Department of Health to reflect the transfer of staff and authority.